Roman J Skoracki, MD | |
1145 Olentangy River Rd, Columbus, OH 43212-3117 | |
(614) 293-0223 | |
(614) 293-7232 |
Full Name | Roman J Skoracki |
---|---|
Gender | Male |
Speciality | Plastic And Reconstructive Surgery |
Experience | 28 Years |
Location | 1145 Olentangy River Rd, Columbus, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477651966 | NPI | - | NPPES |
0112282 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 35123775 (Ohio) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ohio State University State Health System | Columbus, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Osu Plastic Surgery, Llc | 2961677679 | 33 |
News Archive
Researchers at The University of Texas at El Paso's School of Pharmacy have been awarded $1.8 million from the National Heart, Lung and Blood Institute of the National Institutes of Health to study the effects of thirdhand smoke on platelet function and cardiovascular disease such as heart attack and stroke.
Neogen Corporation announced today that its revenues for the fourth quarter of its FY 2012, which ended May 31, increased 11.4% from the previous year's comparable quarter to $48,545,000. Net income for the fiscal year's final quarter was $0.25 per share, the same as the prior year's fourth quarter of $0.25 per share.
Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has granted priority review to the Company's supplemental new drug application (sNDA) for VELCADE. The sNDA contains long-term overall survival (OS) data from the landmark VISTA trial examining the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).
Researchers from Boston University School of Medicine (BUSM) and the Laser and Skin Cancer Center of Indiana, (Carmel, Indiana), found that there has been a dramatic increase in the number of procedures performed and patient demand for dermatologic health care since 2000. The findings, which were recently reported in Dermatologic Surgery, parallels the growth in the age of individuals between the ages of 40 to 55, who make up the "Baby Boomer" generation.
TADA (Teens Against Domestic Abuse), the first organization of its kind created and led by South Florida teens, will hold a panel discussion on November 5th, 2009. Presented by Sapere Group, the event, "Break the Silence: Break the Cycle," is aimed to shed light on domestic violence and how it transcends age, social and ethnic groups.
› Verified 3 days ago
Entity Name | Osu Plastic Surgery, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346533734 PECOS PAC ID: 2961677679 Enrollment ID: O20111208000164 |
News Archive
Researchers at The University of Texas at El Paso's School of Pharmacy have been awarded $1.8 million from the National Heart, Lung and Blood Institute of the National Institutes of Health to study the effects of thirdhand smoke on platelet function and cardiovascular disease such as heart attack and stroke.
Neogen Corporation announced today that its revenues for the fourth quarter of its FY 2012, which ended May 31, increased 11.4% from the previous year's comparable quarter to $48,545,000. Net income for the fiscal year's final quarter was $0.25 per share, the same as the prior year's fourth quarter of $0.25 per share.
Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has granted priority review to the Company's supplemental new drug application (sNDA) for VELCADE. The sNDA contains long-term overall survival (OS) data from the landmark VISTA trial examining the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).
Researchers from Boston University School of Medicine (BUSM) and the Laser and Skin Cancer Center of Indiana, (Carmel, Indiana), found that there has been a dramatic increase in the number of procedures performed and patient demand for dermatologic health care since 2000. The findings, which were recently reported in Dermatologic Surgery, parallels the growth in the age of individuals between the ages of 40 to 55, who make up the "Baby Boomer" generation.
TADA (Teens Against Domestic Abuse), the first organization of its kind created and led by South Florida teens, will hold a panel discussion on November 5th, 2009. Presented by Sapere Group, the event, "Break the Silence: Break the Cycle," is aimed to shed light on domestic violence and how it transcends age, social and ethnic groups.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Roman J Skoracki, MD 700 Ackerman Rd Ste 2120, Columbus, OH 43202-1559 Ph: (614) 293-0223 | Roman J Skoracki, MD 1145 Olentangy River Rd, Columbus, OH 43212-3117 Ph: (614) 293-0223 |
News Archive
Researchers at The University of Texas at El Paso's School of Pharmacy have been awarded $1.8 million from the National Heart, Lung and Blood Institute of the National Institutes of Health to study the effects of thirdhand smoke on platelet function and cardiovascular disease such as heart attack and stroke.
Neogen Corporation announced today that its revenues for the fourth quarter of its FY 2012, which ended May 31, increased 11.4% from the previous year's comparable quarter to $48,545,000. Net income for the fiscal year's final quarter was $0.25 per share, the same as the prior year's fourth quarter of $0.25 per share.
Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has granted priority review to the Company's supplemental new drug application (sNDA) for VELCADE. The sNDA contains long-term overall survival (OS) data from the landmark VISTA trial examining the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).
Researchers from Boston University School of Medicine (BUSM) and the Laser and Skin Cancer Center of Indiana, (Carmel, Indiana), found that there has been a dramatic increase in the number of procedures performed and patient demand for dermatologic health care since 2000. The findings, which were recently reported in Dermatologic Surgery, parallels the growth in the age of individuals between the ages of 40 to 55, who make up the "Baby Boomer" generation.
TADA (Teens Against Domestic Abuse), the first organization of its kind created and led by South Florida teens, will hold a panel discussion on November 5th, 2009. Presented by Sapere Group, the event, "Break the Silence: Break the Cycle," is aimed to shed light on domestic violence and how it transcends age, social and ethnic groups.
› Verified 3 days ago
Dr. Aditya Sood, M.D., M.B.A. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 915 Olentangy River Rd Ste 2140, Columbus, OH 43212 Phone: 614-293-8566 Fax: 614-293-3381 | |
Kim A. Bjorklund, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 555 S 18th St, Columbus, OH 43205 Phone: 614-722-6200 | |
Patrick W Harbour, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 915 Olentangy River Rd Ste 2140, Columbus, OH 43212 Phone: 614-293-8566 Fax: 614-293-3381 | |
Dr. Kerry-ann Stewart Mitchell, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 915 Olentangy River Rd, Columbus, OH 43212 Phone: 614-293-8566 Fax: 614-293-3381 | |
Dr. Cristiane M. Ueno, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 915 Olentangy River Rd, Columbus, OH 43212 Phone: 614-293-8566 Fax: 614-293-3381 | |
Dr. Gan Hok Bing, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3600 Olentangy River Rd Ste 480, Columbus, OH 43214 Phone: 614-457-2233 Fax: 614-457-3012 | |
Dexter W Blome, M.D., PH.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 85 Mcnaughten Rd, Suite 260, Columbus, OH 43213 Phone: 614-755-4155 Fax: 614-755-5104 |